浙江同源康医药股份有限公司（02410）于2026年2月3日披露截至2026年1月31日的股份变动月报表。公告显示，公司当月未有新增发行、购回或注销等股份变动事宜，股本结构维持稳定。
公司注册股本总计为人民币380,065,818元，其中H股股份数为375,457,818股，非上市股份数为4,608,000股。本月报表显示，上述H股与非上市股份数量均无增减，分别保持在375,457,818股和4,608,000股。
根据公告，公司确认当前符合香港联交所主板上市规则所要求的公众持股量规定，且并无股份期权、股权激励计划或可转换债券等相关变动。月报由执行董事、董事长兼总裁吴豫生签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.